"The consumer healthcare market has experienced a steady stream of mergers and acquisitions in recent years. Some of this has created small ripples — like pebbles being gently tossed into still waters. Then there are the mega-mergers that have had a tsunami-like effect," writes Dave Wendland, Hamacher Resource Group VP, in his latest blog entry.
Sanofi on Monday acquired the rights to Afrezza Inhalation Powder, a new rapid-acting inhaled insulin therapy for adults with Type 1 and Type 2 diabetes, from MannKind in a deal that could be worth as much as $925 million.
Capsa Solutions, a provider of medication management systems, mobile computing carts and medical cart platforms for healthcare facilities, announced the acquisition of Kirby Lester, LLC — a provider of automated medication dispensing solutions in retail, institutional, hospital and ambulatory pharmacy settings.
While sales of heat and ice packs are relatively flat — the category generated slight growth of 0.2% to $235.9 million for the 52 weeks ended April 20 across total U.S. multi-outlets, according to IRI — there has been some positive momentum within the category.
Roche on Wednesday announced that Genentech, a member of the Roche Group, has entered into a definitive agreement to acquire Seragon Pharmaceuticals, a privately held biotechnology company based in San Diego.
Kroger and Vitacost.com on Wednesday announced a definitive merger agreement under which Kroger will purchase all outstanding shares of Vitacost.com for $8 per share in cash, or approximately $280 million.
Performance Health, the manufacturer and marketer behind TheraBand, Biofreeze, Perform, Cramer, Bon Vital' and Hygenic products, last week announced that it acquired TheraPearl, the creator of hot and cold therapy products.
In preparation for the grand re-opening of the Rite Aid located at 300 North Canon Dr. in Beverly Hills, the company on Thursday announced it will kick off the celebration by hosting 21 days of special events for customers.
Teva Pharmaceutical and Labrys Biologics, a privately-held development stage biotechnology company focused on treatments for chronic migraine and episodic migraine, on Tuesday announced that Teva has entered into a definitive agreement to acquire Labrys in a deal for $200 million in upfront payment in cash at closing as well as up to $625 million in contingent payments upon achievement of certain pre-launch milestones.
Gov. Alejandro García Padilla on Wednesday announced an agreement by Puerto Rico Industrial Development Co. with Actavis that will allow the pharmaceutical manufacturer to develop a solid dosage manufacturing and packing facility in its Manati site and expand its current hormone production in Fajardo.
As one of a handful of founding officers at Take Care Health Systems — now known as the Healthcare Clinics at Walgreens — and the first chief nurse practitioner officer in the convenient care industry, Sandy Ryan’s role in the industry’s growth has been significant, to say the least.